The European Society for Medical Oncology (ESMO) has submitted its response to the European Commission’s consultation on the EU Multiannual Financial Framework (MFF) 2028–2034, calling for cancer to remain a flagship investment priority within the proposed European Competitiveness Fund (ECF).
